Cytosorbents Corp
NASDAQ:CTSO

  • LAST PRICE
    0.9096
  • TODAY'S CHANGE (%)
    0.0996 (12.2963%)
  • Bid / Lots
    0.8710/ 10
  • Ask / Lots
    0.9500/ 43
  • Open / Previous Close
    0.8300 / 0.8100
  • Day Range
    0.8000
    0.9501
  • 52 Week Range
    0.7820
    4.2900
  • Volume
    180,820

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • May 9, 2024

      Show headlines and story abstract

    • 4:18PM ET on Thursday May 09, 2024 by MT Newswires
      Companies Mentioned: CTSO
      04:18 PM EDT, 05/09/2024 (MT Newswires) -- ...

    • 4:17PM ET on Thursday May 09, 2024 by GlobeNewswire
      Companies Mentioned: CTSO

    • 4:17PM ET on Thursday May 09, 2024 by Dow Jones
      Companies Mentioned: CTSO
      Miscellaneous income (expense) --- (32) ----------- ---------- Total other income (expense), net (1,433) 566 ----------- ---------- Loss before benefit from income taxes (6,358) (7,326) Benefit from income taxes --- --- ----------- ---------- Net loss (6,358) (7,326) =========== ========== Earnings per share: Basic and diluted loss per share $ (0.12) $ (0.17) =========== ========== Weighted average share outstanding 54,262,790 43,676,435 =========== ========== Net Loss $ (6,358) $ (7,326) Other comprehensive income (loss): Foreign currency translation adjustment 1,223 (608) ----------- ---------- Comprehensive loss $ (5,135) $ (7,934) =========== ========== CYTOSORBENTS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (amounts in thousands) March 31, 2024 December 31, 2023 ASSETS: Current Assets: Cash and cash equivalents $ 8,608 $ 14,131 Grants and accounts receivable, net 6,766 6,057 Inventories 3,739 3,680 Prepaid expenses and other current assets 880 1,835 -------------- ----------------- Total current assets 19,993 25,703 Property and equipment, net 9,749 10,056 Restricted Cash 1,484 1,484 Right of use asset 11,925 12,059 Other assets 3,920 3,959 -------------- ----------------- TOTAL ASSETS $ 47,071 $ 53,261 ============== ================= LIABILITIES AND STOCKHOLDERS' EQUITY: Current Liabilities: Accounts payable $ 2,399 $ 3,802 Lease liability - current portion 393 374 Accrued expenses and other current liabilities 8,132 7,870 Current maturities of long-term debt 2,500 2,500 Total current liabilities 13,424 14,546 Lease liability, net of current portion 12,790 12,897 Long-term debt 1,929 2,543 TOTAL LIABILITIES 28,143 29,986 Total stockholders' equity 18,928 23,275 -------------- ----------------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 47,071 $ 53,261 ============== =================

    • 4:17PM ET on Thursday May 09, 2024 by Dow Jones
      Companies Mentioned: CTSO
      Miscellaneous income (expense) --- (32) ----------- ---------- Total other income (expense), net (1,433) 566 ----------- ---------- Loss before benefit from income taxes (6,358) (7,326) Benefit from income taxes --- --- ----------- ---------- Net loss (6,358) (7,326) =========== ========== Earnings per share: Basic and diluted loss per share $ (0.12) $ (0.17) =========== ========== Weighted average share outstanding 54,262,790 43,676,435 =========== ========== Net Loss $ (6,358) $ (7,326) Other comprehensive income (loss): Foreign currency translation adjustment 1,223 (608) ----------- ---------- Comprehensive loss $ (5,135) $ (7,934) =========== ========== CYTOSORBENTS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (amounts in thousands) March 31, 2024 December 31, 2023 ASSETS: Current Assets: Cash and cash equivalents $ 8,608 $ 14,131 Grants and accounts receivable, net 6,766 6,057 Inventories 3,739 3,680 Prepaid expenses and other current assets 880 1,835 -------------- ----------------- Total current assets 19,993 25,703 Property and equipment, net 9,749 10,056 Restricted Cash 1,484 1,484 Right of use asset 11,925 12,059 Other assets 3,920 3,959 -------------- ----------------- TOTAL ASSETS $ 47,071 $ 53,261 ============== ================= LIABILITIES AND STOCKHOLDERS' EQUITY: Current Liabilities: Accounts payable $ 2,399 $ 3,802 Lease liability - current portion 393 374 Accrued expenses and other current liabilities 8,132 7,870 Current maturities of long-term debt 2,500 2,500 Total current liabilities 13,424 14,546 Lease liability, net of current portion 12,790 12,897 Long-term debt 1,929 2,543 TOTAL LIABILITIES 28,143 29,986 Total stockholders' equity 18,928 23,275 -------------- ----------------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 47,071 $ 53,261 ============== =================

  • May 7, 2024

Peers Headlines